RÉSUMÉ
Cyathostomins are the largest group of parasites in horses that can be controlled by ivermectin (IVM). This study aimed to run a four-dose titration trial of IVM in 28 naturally infected Thoroughbred yearlings. The local Strongyle population had been recorded to be resistant to IVM (200 µg/kg). The parasite fecal egg count (FEC) was performed to investigate the egg reappearance period (ERP) of two and five weeks (w2pt and w5pt) after IVM treatment. FEC was > 1000 on day zero for all groups. Although 100% FEC reduction was reported at w2pt for all concentrations, the FEC at w5pt revealed < 83% efficacy. This study reports the reduction of ERP using the label dose as well as 300, and 400 µg/kg (double dose) of IVM. The protocol allowed IVM to significantly suppress FEC w2pt although not eliminating adult worms, failing to guarantee an extension of its protection period over 8 weeks. Moreover, the FEC at w5pt possibly means the infection was not cleared, and worms reestablished egg laying. We raised the possibility of withdrawing IVM of control programs when the drug has less than 80% FEC reduction at w5pt.
Sujet(s)
Ivermectine , Numération des oeufs de parasites , Animaux , Ivermectine/usage thérapeutique , Ivermectine/administration et posologie , Equus caballus/parasitologie , Brésil , Maladies des chevaux/parasitologie , Maladies des chevaux/traitement médicamenteux , Maladies des chevaux/diagnostic , Femelle , Antiparasitaires/usage thérapeutique , Antiparasitaires/administration et posologie , Strongylose équine/traitement médicamenteux , Strongylose équine/parasitologie , Strongylose équine/diagnostic , Fèces/parasitologieRÉSUMÉ
Digenetic trematodes form a major group of human parasites, affecting a large number of humans, especially in endemic foci. Over 100 species have been reported infecting humans, including blood, lung, liver and intestinal parasites. Traditionally, trematode infections have been diagnosed by parasitological methods based on the detection and the identification of eggs in different clinical samples. However, this is complicated due to the morphological similarity between eggs of different trematode species and other factors such as lack of sensitivity or ectopic locations of the parasites. Moreover, the problem is currently aggravated by migratory flows, international travel, international trade of foods and changes in alimentary habits. Although efforts have been made for the development of immunological and molecular techniques, the detection of eggs through parasitological techniques remains as the gold standard for the diagnosis of trematodiases. In the present chapter, we review the current status of knowledge on diagnostic techniques used when examining feces, urine, and sputum and also analyze the most relevant characteristics used to identify eggs with a quick key for the identification of eggs.
Sujet(s)
Fèces , Trematoda , Infections à trématodes , Humains , Infections à trématodes/diagnostic , Infections à trématodes/parasitologie , Animaux , Fèces/parasitologie , Expectoration/parasitologie , Numération des oeufs de parasites/méthodesRÉSUMÉ
Some helminth test methods for sanitation samples include a phase extraction step to reduce lipid content and final pellet size before microscopy. Hydrophilic and lipophilic solutions are used to create 2 phases, with a plug of organic material or debris in between, whilst eggs are supposedly compacted at the bottom of the test tube. We tested 10% formalin, acetoacetic buffer, and acid alcohol as the hydrophilic solutions, and ethyl acetate and diethyl ether as the lipophilic solvents for egg recoverability from water, primary sludge, and fatty sludge. Normally, the supernatant and debris plug are discarded and the sedimented pellet of eggs is microscopically examined. We, however, also collected the entire supernatant plus debris plug to determine where eggs were possibly lost. We found that eggs were lost when samples were extracted with 10% formalin + ethyl acetate, 10% formalin + diethyl ether, acetoacetic buffer + ethyl acetate, and acetoacetic buffer + diethyl ether combinations (<50% egg recovery). Acid alcohol + ethyl acetate resulted in 93.2, 89.8, and 57.3% egg recovery in the pellet of water, primary sludge, and fatty sludge, respectively; however, the size of the final pellet was not reduced, defeating the purpose of the extraction step. We thus recommend that this step be excluded.
Sujet(s)
Ascaris suum , Eaux d'égout , Animaux , Eaux d'égout/parasitologie , Eaux d'égout/composition chimique , Ascaris suum/isolement et purification , Ovule , Formaldéhyde/pharmacologie , Suidae , Numération des oeufs de parasites/médecine vétérinaire , Acétates/composition chimique , Solvants/composition chimiqueRÉSUMÉ
The present study aims to assess the performance of different molecular targets using various matrices of samples for the detection of Uncinaria stenocephala (US) in hookworm infected dogs. To this end, the DNA extraction was performed on the following matrices of samples: (i) larvae of US obtained from experimentally infected dogs with US with different larvae counts per microliter (µl); (ii) pure US eggs suspension in distilled water with different egg counts per µl; (iii) spiked dog fecal samples with different US eggs per gram (EPG) of feces; (iv) feces from dogs naturally infected with hookworm eggs; (v) fecal suspension with hookworm eggs recovered from the FLOTAC apparatus. All the samples were tested with four different PCR protocols targeting specific regions for the detection of both hookworms US and AC as follows: Protocol A (ITS1, 5.8â¯S, ITS2) and Protocol B (18â¯S) for the detection of both species, Protocol C (ITS1) for the detection of AC and Protocol D (ITS1) for the detection of US. The best results were obtained with DNA extracted from US larvae matrix obtained from experimentally infected dogs, showing a detection limit of 3.5 larvae/ml for the protocols A, B and D. A moderate correlation was found between the FLOTAC technique and PCR protocols B and D with respect to fecal samples from dogs naturally infected with hookworms. Indeed, PCR protocols B (18â¯S) and D (ITS1) gave the best results for feces and fecal suspension from naturally infected dogs. However, all the PCR protocols used showed lower sensitivity than FLOTAC technique. Perhaps, isolating US eggs in advance could help to obtain better quality and quantity of DNA, avoiding some notable factors such as inhibitors present in faecal samples. However, a further study is needed to evaluate and standardise a protocol for the recovery of parasitic elements, that could be applied prior to DNA extraction. Therefore, this could lead to a better amplification of US eggs DNA. In conclusion, our results showed that the type of sample (sample-matrix) used for the DNA extraction samples is crucial, as this affects the diagnostic sensitivity of the technique.
Sujet(s)
Ancylostomatoidea , Maladies des chiens , Fèces , Infections à ankylostomes , Réaction de polymérisation en chaîne , Animaux , Chiens , Maladies des chiens/parasitologie , Maladies des chiens/diagnostic , Fèces/parasitologie , Ancylostomatoidea/isolement et purification , Ancylostomatoidea/génétique , Infections à ankylostomes/médecine vétérinaire , Infections à ankylostomes/diagnostic , Infections à ankylostomes/parasitologie , Réaction de polymérisation en chaîne/médecine vétérinaire , Réaction de polymérisation en chaîne/méthodes , ADN des helminthes/isolement et purification , ADN des helminthes/analyse , Numération des oeufs de parasites/médecine vétérinaire , Numération des oeufs de parasites/méthodes , Larve , Sensibilité et spécificitéRÉSUMÉ
Changes to the faecal microbiota of horses associated with administration of anthelmintic drugs is poorly defined. This study included horses with cyathostomin infection where susceptibility and resistance to oxfendazole and abamectin was known. This study assessed the changes to the faecal microbiota associated with administration of two different anthelmintics in this population. Twenty-four adult horses were included. Faecal egg counts were performed on all horses prior to random allocation into abamectin (n=8), oxfendazole (n=8) or Control groups (n=8) and at Day 14 post treatment. Faecal samples were collected for microbiota analysis prior to anthelmintic administration and on Day 3 and Day 14. From each faecal sample, DNA was extracted prior to PCR amplification, next generation sequencing and analysis using QIIME2. Anthelmintic treatment was associated with changes in alpha diversity (p <0.05), with increased evenness and diversity at Day 14 and increased richness at Day 3 within the abamectin group. Differences in relative abundance of bacteria at the phyla, family and genus taxonomic levels occurred after treatment; indicating that the microbiota was altered with anthelmintic administration. The results support that anthelmintic administration and removal of cyathostomins from the large intestine of horses is associated with changes in the faecal microbiota. The results suggest that removal of cyathostomins is associated with greater differences in microbiota, compared to anthelmintic drug administration that is ineffective in reducing cyathostomin infection. Cyathostomin removal was supported by adequate reduction of faecal egg counts, determined by faecal egg count reduction testing.
Sujet(s)
Anthelminthiques , Fèces , Maladies des chevaux , Ivermectine , Numération des oeufs de parasites , Animaux , Equus caballus , Anthelminthiques/pharmacologie , Anthelminthiques/usage thérapeutique , Anthelminthiques/administration et posologie , Fèces/parasitologie , Fèces/microbiologie , Ivermectine/analogues et dérivés , Ivermectine/pharmacologie , Ivermectine/usage thérapeutique , Maladies des chevaux/traitement médicamenteux , Maladies des chevaux/parasitologie , Maladies des chevaux/microbiologie , Numération des oeufs de parasites/médecine vétérinaire , Femelle , Mâle , Microbiote/effets des médicaments et des substances chimiques , BenzimidazolesRÉSUMÉ
The general aim of this study is to analyse the risk factors for gastrointestinal parasitosis in small ruminants in order to contribute to the emergence of targeted treatment methods, at herd and agro-climatic zone levels, for the integrated and sustainable management of parasitic diseases in Sahelian livestock systems. The methodology was based on a questionnaire survey conducted in 37 villages and coprological analysis using the McMaster method on faecal samples from 968 small ruminants, including 555 goats and 413 sheep. Multiple logistic regression was used to highlight the risk factors associated with each type of parasitosis encountered. The results showed that the most widespread farming system remained 100% traditional, with feeding based essentially on natural grazing. Coprological results showed the prevalence of nematodosis (70.2%), Cestodosis (4.1%) and Coccidiosis (79.9%), with an average prevalence of coinfection of 56.9%. These parasite loads were significantly higher during the rainy season and in the more arid northern Sahelian zone, with a marked reduction at the end of the season. Average parasitic egg excretions were 1089 EPG of nematodes and 6864 EPG of coccidia. Parasite loads were higher in the wetter southern strip and varied significantly by breed. Of the five breeds of small ruminants studied, the ara-ara sheep had the highest parasitic loads and prevalences for nematodosis (78.6%), coccidiosis (89,3%) and coinfection (70.9%), appears to be the most susceptible to parasitosis. As for risk factors for severe parasite pressure, animals at the end of the rainy season, older animals and those with poor body condition were at risk of nematodiasis or coinfection. On the other hand, animals at the beginning of the rainy season, farms located in less arid southern Sahelian zones and male subjects were the groups at significant risk of coccidiosis. In these extensive Sahelian farming conditions, the control of these parasitoses by selective treatment of animals could be developed, targeting in particular the risk groups highlighted in this study.
Sujet(s)
Maladies des chèvres , Capra , Maladies des ovins , Animaux , Facteurs de risque , Prévalence , Maladies des ovins/épidémiologie , Maladies des ovins/parasitologie , Ovis , Maladies des chèvres/parasitologie , Maladies des chèvres/épidémiologie , Capra/parasitologie , Mâle , Femelle , Niger/épidémiologie , Fèces/parasitologie , Coccidiose/médecine vétérinaire , Coccidiose/épidémiologie , Coccidiose/parasitologie , Saisons , Parasitoses intestinales/médecine vétérinaire , Parasitoses intestinales/épidémiologie , Parasitoses intestinales/parasitologie , Élevage/méthodes , Maladies gastro-intestinales/médecine vétérinaire , Maladies gastro-intestinales/parasitologie , Maladies gastro-intestinales/épidémiologie , Enquêtes et questionnaires , Nématodoses/médecine vétérinaire , Nématodoses/épidémiologie , Nématodoses/parasitologie , Numération des oeufs de parasites/médecine vétérinaireRÉSUMÉ
The objective of this study was to identify genomic regions and genes associated with resistance to gastrointestinal nematodes in Australian Merino sheep in Uruguay, using the single-step GWAS methodology (ssGWAS), which is based on genomic estimated breeding values (GEBVs) obtained from a combination of pedigree, genomic, and phenotypic data. This methodology converts GEBVs into SNP effects. The analysis included 26,638 animals with fecal egg count (FEC) records obtained in two independent parasitic cycles (FEC1 and FEC2) and 1700 50K SNP genotypes. The comparison of genomic regions was based on genetic variances (gVar(%)) explained by non-overlapping regions of 20 SNPs. For FEC1 and FEC2, 18 and 22 genomic windows exceeded the significance threshold (gVar(%) ≥ 0.22%), respectively. The genomic regions with strong associations with FEC1 were located on chromosomes OAR 2, 6, 11, 21, and 25, and for FEC2 on OAR 5, 6, and 11. The proportion of genetic variance attributed to the top windows was 0.83% and 1.9% for FEC1 and FEC2, respectively. The 33 candidate genes shared between the two traits were subjected to enrichment analysis, revealing a marked enrichment in biological processes related to immune system functions. These results contribute to the understanding of the genetics underlying gastrointestinal parasite resistance and its implications for other productive and welfare traits in animal breeding programs.
Sujet(s)
Polymorphisme de nucléotide simple , Maladies des ovins , Animaux , Ovis/parasitologie , Ovis/génétique , Maladies des ovins/génétique , Maladies des ovins/parasitologie , Résistance à la maladie/génétique , Étude d'association pangénomique , Nématodoses/génétique , Nématodoses/médecine vétérinaire , Nématodoses/parasitologie , Australie , Numération des oeufs de parasites/médecine vétérinaire , Parasitoses intestinales/génétique , Parasitoses intestinales/médecine vétérinaire , Parasitoses intestinales/parasitologieRÉSUMÉ
The population of South American camelids (SAC) has been steadily growing in Europe, where they are confronted with the regional endoparasite population of ruminants. As there are no anthelmintic drugs registered for use against nematode infections in SACs, anthelmintics (AH) available for ruminants or horses are usually applied. Reports indicating potential failures in administered AH are increasing. However, the generally low egg counts in SACs complicate the application of resistance tests in the field. The present study reports a follow-up study on SAC farms where anthelmintic resistance (AR) was suspected. The aims were (i) to repeat faecal egg count reduction tests (FECRTs) on potentially affected farms identified in a previous study with larger sample sizes, (ii) to verify suspected AR of Haemonchus contortus against benzimidazoles (BZ) by performing a single-nucleotide polymorphism (SNP) analysis using digital polymerase chain reaction (dPCR), and (iii) to apply the mini-FLOTAC technique for more reliable results at low egg counts in line with current recommendations. Seven farms (9-46 animals each) were examined by coproscopy, larval differentiation and SNP analysis. A FECRT was performed on six of these farms with moxidectin (three farms), monepantel (two farms) and ivermectin (one farm). The FEC was calculated according to the current World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines with the clinical protocol (a newly introduced variant of FECRT which can be used for smaller sample sizes and lower egg counts on the cost of sensitivity) and an expected efficacy of 99%. A high level (> 90%) of BZ-resistance-associated SNPs on codon 200 of H. contortus was observed on all farms. With the FECRT, resistance was demonstrated for ivermectin (74% FECR), while it remained inconclusive for one farm for moxidectin treatment. Sustained efficacy was demonstrated for the remaining treatments. This study showed an advanced level of BZ resistance in H. contortus of SACs and the development of AR against macrocyclic lactones on some farms. Thus, constant monitoring of AH treatment and sustainable worm control methods both need to be applied.
Sujet(s)
Anthelminthiques , Benzimidazoles , Camélidés du Nouveau Monde , Résistance aux substances , Fèces , Infections à Haemonchus , Haemonchus , Numération des oeufs de parasites , Animaux , Haemonchus/effets des médicaments et des substances chimiques , Haemonchus/génétique , Résistance aux substances/génétique , Anthelminthiques/pharmacologie , Infections à Haemonchus/médecine vétérinaire , Infections à Haemonchus/parasitologie , Infections à Haemonchus/traitement médicamenteux , Numération des oeufs de parasites/médecine vétérinaire , Benzimidazoles/pharmacologie , Fèces/parasitologie , Camélidés du Nouveau Monde/parasitologie , Allèles , Polymorphisme de nucléotide simple , Lactones/pharmacologie , Allemagne , Macrolides/pharmacologieRÉSUMÉ
Fasciolosis, a globally re-emerging zoonotic disease, is mostly caused by the parasitic infection with Fasciola hepatica, often known as the liver fluke. This disease has a considerable impact on livestock productivity. This study aimed to evaluate the fluke burdens and faecal egg counts in goats that were administered phage clones of cathepsin L mimotopes and then infected with F. hepatica metacercariae. Additionally, the impact of vaccination on the histology of the reproductive system, specifically related to egg generation in adult parasites, was examined. A total of twenty-four goats, which were raised in sheds, were divided into four groups consisting of six animals each. These groups were randomly assigned. The goats were then subjected to two rounds of vaccination. Each vaccination involved the administration of 1 × 1013 phage particles containing specific mimotopes for cathepsin L2 (group 1: PPIRNGK), cathepsin L1 (group 2: DPWWLKQ), and cathepsin L1 (group 3: SGTFLFS). The immunisations were carried out on weeks 0 and 4, and the Quil A adjuvant was used in combination with the mimotopes. The control group was administered phosphate-buffered saline (PBS) (group 4). At week 6, all groups were orally infected with 200 metacercariae of F. hepatica. At week 22 following the initial immunisation, the subjects were euthanised, and adult F. hepatica specimens were retrieved from the bile ducts and liver tissue, and subsequently quantified. The specimens underwent whole-mount histology for the examination of the reproductive system, including the testis, ovary, vitellaria, Mehlis' gland, and uterus. The mean fluke burdens following the challenge were seen to decrease by 50.4%, 62.2%, and 75.3% (p < 0.05) in goats that received vaccinations containing cathepsin L2 PPIRNGK, cathepsin L1 DPWWLKQ, and cathepsin L1 SGTFLFS, respectively. Animals that received vaccination exhibited a significant reduction in the production of parasite eggs. The levels of IgG1 and IgG2 isotypes in vaccinated goats were significantly higher than in the control group, indicating that protection is associated with the induction of a mixed Th1/Th2 immune response. The administration of cathepsin L to goats exhibits a modest level of efficacy in inducing histological impairment in the reproductive organs of liver flukes, resulting in a reduction in egg output.
Sujet(s)
Cathepsine L , Fasciola hepatica , Fasciolase , Capra , Vaccination , Animaux , Fasciola hepatica/immunologie , Cathepsine L/métabolisme , Fasciolase/médecine vétérinaire , Fasciolase/prévention et contrôle , Fasciolase/immunologie , Fasciolase/parasitologie , Vaccination/méthodes , Femelle , Mâle , Maladies des chèvres/parasitologie , Maladies des chèvres/prévention et contrôle , Maladies des chèvres/immunologie , Numération des oeufs de parasites , Bactériophages/immunologieRÉSUMÉ
BACKGROUND: The bovine lungworm Dictyocaulus viviparus negatively impacts bovine health and leads to substantial economic losses. Lungworm infections can be difficult to manage due to the unpredictable and severe nature of clinical outbreaks. Despite the widespread use of macrocyclic lactones (MLs) in grazing cattle in the UK, there have been no confirmed reports of resistant lungworms to date, with only one case of anthelmintic-resistant (ML) lungworm confirmed worldwide. METHODS: Lungworm Baermann filtrations were conducted on first-season grazing dairy calves as part of a wider study investigating anthelmintic resistance in gastrointestinal nematodes in Scotland using the faecal egg count reduction test. RESULTS: Clinical signs and significant numbers of lungworm larvae in faeces were observed after treatment with either ivermectin or moxidectin. LIMITATIONS: There are no established guidelines for the diagnosis of resistant lungworms in the field. Currently, resistance can only be diagnosed after a controlled efficacy test has been conducted. This limits the conclusions that can be drawn; however, they are highly suggestive of resistance. CONCLUSION: This short report describes the inefficacy of ivermectin and moxidectin against D. viviparus and is highly suggestive of ML resistance.
Sujet(s)
Maladies des bovins , Dictyocauloses , Dictyocaulus , Ivermectine , Macrolides , Animaux , Ivermectine/usage thérapeutique , Ivermectine/pharmacologie , Bovins , Macrolides/usage thérapeutique , Macrolides/pharmacologie , Dictyocauloses/traitement médicamenteux , Maladies des bovins/traitement médicamenteux , Maladies des bovins/parasitologie , Dictyocaulus/effets des médicaments et des substances chimiques , Anthelminthiques/usage thérapeutique , Anthelminthiques/pharmacologie , Écosse , Résistance aux substances , Femelle , Fèces/parasitologie , Industrie laitière , Numération des oeufs de parasites/médecine vétérinaireRÉSUMÉ
BACKGROUND: Digital imaging combined with deep-learning-based computational image analysis is a growing area in medical diagnostics, including parasitology, where a number of automated analytical devices have been developed and are available for use in clinical practice. METHODS: The performance of Parasight All-in-One (AIO), a second-generation device, was evaluated by comparing it to a well-accepted research method (mini-FLOTAC) and to another commercially available test (Imagyst). Fifty-nine canine and feline infected fecal specimens were quantitatively analyzed by all three methods. Since some samples were positive for more than one parasite, the dataset consisted of 48 specimens positive for Ancylostoma spp., 13 for Toxocara spp. and 23 for Trichuris spp. RESULTS: The magnitude of Parasight AIO counts correlated well with those of mini-FLOTAC but not with those of Imagyst. Parasight AIO counted approximately 3.5-fold more ova of Ancylostoma spp. and Trichuris spp. and 4.6-fold more ova of Toxocara spp. than the mini-FLOTAC, and counted 27.9-, 17.1- and 10.2-fold more of these same ova than Imagyst, respectively. These differences translated into differences between the test sensitivities at low egg count levels (< 50 eggs/g), with Parasight AIO > mini-FLOTAC > Imagyst. At higher egg counts Parasight AIO and mini-FLOTAC performed with comparable precision (which was significantly higher that than Imagyst), whereas at lower counts (> 30 eggs/g) Parasight was more precise than both mini-FLOTAC and Imagyst, while the latter two methods did not significantly differ from each other. CONCLUSIONS: In general, Parasight AIO analyses were both more precise and sensitive than mini-FLOTAC and Imagyst and quantitatively correlated well with mini-FLOTAC. While Parasight AIO produced lower raw counts in eggs-per-gram than mini-FLOTAC, these could be corrected using the data generated from these correlations.
Sujet(s)
Maladies des chats , Maladies des chiens , Fèces , Numération des oeufs de parasites , Animaux , Chats , Chiens , Fèces/parasitologie , Maladies des chiens/parasitologie , Maladies des chiens/diagnostic , Numération des oeufs de parasites/méthodes , Numération des oeufs de parasites/médecine vétérinaire , Numération des oeufs de parasites/instrumentation , Maladies des chats/parasitologie , Maladies des chats/diagnostic , Toxocara/isolement et purification , Ancylostoma/isolement et purification , Trichuris/isolement et purification , Helminthes/isolement et purification , Helminthes/classification , Helminthoses animales/diagnostic , Helminthoses animales/parasitologie , OvuleRÉSUMÉ
BACKGROUND: Reliance on praziquantel for the treatment and control of schistosomiasis is likely to facilitate the emergence of drug resistance. Combination therapy targeting adult and juvenile schistosome worms is urgently needed to improve praziquantel efficacy and delay the potential development of drug resistance. We assessed the efficacy and safety of single-dose praziquantel combined with single-dose artesunate plus sulfalene-pyrimethamine in the treatment of Kenyan children with schistosomiasis. METHODS: This was an open-label, randomised clinical trial involving 426 school-aged children (7-15 years old) diagnosed with Schistosoma mansoni (by Kato-Katz) or S. haematobium (by urine filtration). They were randomly assigned (1:1:1) to receive a single dose of praziquantel (40 mg/kg), a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate) or combination therapy using a single dose of praziquantel (40 mg/kg) combined with a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate). The primary outcome was cure and egg reduction rates at 6 weeks post-treatment in the available case population. Adverse events were assessed within 3 h after treatment. RESULTS: Of the 426 children enrolled, 135 received praziquantel, 150 received artesunate plus sulfalene-pyrimethamine, and 141 received combination therapy. Outcome data were available for 348 (81.7%) children. For S. mansoni-infected children (n = 335), the cure rates were 75.6%, 60.7%, and 77.8%, and the egg reduction rates were 80.1%, 85.0%, and 88.4% for praziquantel, artesunate plus sulfalene-pyrimethamine, and combination therapy, respectively. For S. haematobium-infected children (n = 145), the corresponding cure rates were 81.4%, 71.1%, and 82.2%, and the egg reduction rates were 95.6%, 97.1%, and 97.7%, respectively. Seventy-one (16.7%) children reported mild-intensity adverse events. The drugs were well tolerated and no serious adverse events were reported. CONCLUSIONS: A single oral dose of praziquantel combined with artesunate plus sulfalene-pyrimethamine cured a high proportion of children with S. haematobium but did not significantly improve the treatment efficacy for either urinary or intestinal schistosomiasis. Sequential administration of praziquantel and artesunate plus sulfalene-pyrimethamine may enhance the efficacy and safety outcomes.
Sujet(s)
Anthelminthiques , Artémisinines , Artésunate , Association de médicaments , Praziquantel , Pyriméthamine , Schistosoma haematobium , Schistosoma mansoni , Bilharziose urinaire , Schistosomiase à Schistosoma mansoni , Humains , Enfant , Praziquantel/administration et posologie , Praziquantel/effets indésirables , Praziquantel/usage thérapeutique , Pyriméthamine/administration et posologie , Pyriméthamine/usage thérapeutique , Pyriméthamine/effets indésirables , Animaux , Adolescent , Artésunate/administration et posologie , Artésunate/usage thérapeutique , Femelle , Mâle , Schistosomiase à Schistosoma mansoni/traitement médicamenteux , Schistosoma haematobium/effets des médicaments et des substances chimiques , Bilharziose urinaire/traitement médicamenteux , Schistosoma mansoni/effets des médicaments et des substances chimiques , Kenya , Artémisinines/administration et posologie , Artémisinines/usage thérapeutique , Artémisinines/effets indésirables , Résultat thérapeutique , Anthelminthiques/administration et posologie , Anthelminthiques/effets indésirables , Anthelminthiques/usage thérapeutique , Sulfalène/administration et posologie , Sulfalène/usage thérapeutique , Sulfalène/effets indésirables , Association médicamenteuse , Numération des oeufs de parasitesRÉSUMÉ
In Argentina, as in the rest of the world, cyathostomins are the most common nematodes parasitizing horses. Control is based almost exclusively on the administration of benzimidazoles, pyrimidines, and macrocyclic lactones. However, intensive use of these drugs is resulting in the development of anthelmintic resistance (AR). For example, AR to benzimidazoles is currently distributed throughout Argentina, while incipient AR to pyrimidines (pyrantel embonate) is appearing in areas where this drug is used. Macrocyclic lactones and especially ivermectin, are by far the most used drugs by the vast majority of equine premises in the country. Although ivermectin has been used since 1982, its efficacy against equine strongylid parasites has remained very high until the present. In this study we report for the first time, the presence of a cyathostomin population with resistance to ivermectin in adult horses belonging to an equine premise located in central Argentina. Fecal egg count reduction tests (FECRT) were performed following the most recent guidelines of the World Association for the Advancement of Veterinary Parasitology (WAAVP) for the diagnosis of anthelmintic resistance (research protocol) and resistance was considered when the Upper 90% Credible Interval fell below the expected efficacy threshold of 99.9%. Calculations were carried out using two different online calculation interfaces suggested by WAAVP. For the 14-day post-treatment interval, ivermectin efficacy was 79.5% (90% Credible Interval: 68.1-88.8) and 79.3% (74.2-83.6.3%) with the two methods, respectively. At 19 days post treatment, fecal egg count reductions were 68.6% (50.5-83.1) and 68.4% (61.9-74.1), respectively. At both intervals, this cyathostomin population fullfilled the criteria for AR. These findings suggest dispersion of ivermectin resistant cyathostomins in Argentina. Given the widespread use of macrocyclic lactones, it is important that veterinarians and the equine industry promote a more selective and evidence-based use of these drugs and establish routine monitoring to determine anthelmintic field efficacy to detect treatment failures as early as possible and avoid potential health problems as well as further spread of resistant genes.
Sujet(s)
Résistance aux substances , Ivermectine , Numération des oeufs de parasites , Animaux , Equus caballus , Ivermectine/pharmacologie , Ivermectine/usage thérapeutique , Argentine , Numération des oeufs de parasites/médecine vétérinaire , Strongylose équine/traitement médicamenteux , Strongylose équine/parasitologie , Anthelminthiques/pharmacologie , Fèces/parasitologie , Maladies des chevaux/traitement médicamenteux , Maladies des chevaux/parasitologie , Strongyloidea/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: The impact of Schistosoma mansoni infection over the immune response and the mechanisms involved in pathogenesis are not yet completely understood. OBJECTIVES: This study aimed to evaluate the expression of innate immune receptors in three distinct mouse lineages (BALB/c, C57BL/6 and Swiss) during experimental S. mansoni infection with LE strain. METHODS: The parasite burden, intestinal tissue oogram and presence of hepatic granulomas were evaluated at 7- and 12-weeks post infection (wpi). The mRNA expression for innate Toll-like receptors, Nod-like receptors, their adaptor molecules, and cytokines were determined at 2, 7 and 12 wpi in the hepatic tissue by real-time quantitative polymerase chain reaction (qPCR). FINDINGS: Swiss mice showed 100% of survival, had lower parasite burden and intestinal eggs, while infected BALB/c and C57BL/6 presented 80% and 90% of survival, respectively, higher parasite burden and intestinal eggs. The three mouse lineages displayed distinct patterns in the expression of innate immune receptors, their adaptor molecules and cytokines, at 2 and 7 wpi. MAIN CONCLUSIONS: Our results suggest that the pathogenesis of S. mansoni infection is related to a dynamic early activation of innate immunity receptors and cytokines important for the control of developing worms.
Sujet(s)
Cytokines , Immunité innée , Souris de lignée BALB C , Souris de lignée C57BL , Schistosomiase à Schistosoma mansoni , Animaux , Schistosomiase à Schistosoma mansoni/immunologie , Immunité innée/immunologie , Cytokines/immunologie , Souris , Schistosoma mansoni/immunologie , Modèles animaux de maladie humaine , Femelle , Récepteurs de type Toll/immunologie , Réaction de polymérisation en chaine en temps réel , Numération des oeufs de parasites , Mâle , ARN messager , Récepteurs immunologiques/génétique , Récepteurs immunologiques/immunologieRÉSUMÉ
In Sudan, resistance to benzimidazoles has been reported recently in cattle and goats from South Darfur. Herein, ivermectin efficacy against gastrointestinal nematodes (GINs) was evaluated in sheep and goats in three study areas in South Darfur. The faecal egg count reduction test (FECRT) was used to evaluate the efficacy of ivermectin in sheep and goats naturally infected with GINs in the region of Bulbul (goats: n = 106), Kass (goats: n = 40) and Nyala (Domaia (sheep: n = 47, goats: n = 77) and the University farm (goats: n = 52)), using different treatment plans, and the efficacy was evaluated 12 days after treatment. Ivermectin efficacy was also evaluated in goats experimentally infected using local Haemonchus contortus isolates from Kass and Nyala. Nematodes surviving ivermectin treatment in goats in Bulbul and Nyala were harvested and larvae used to infect worm-free male sheep (n = 6, ≤6 months old). Infected sheep were dosed subcutaneously with ivermectin every eight days with increasing doses from 0.2 mg/kg to 1.6 mg/kg bodyweight (bw). Reduced ivermectin efficacy was identified in sheep and goats in the four study locations. Using a paired statistic, the efficacy of a therapeutic dose in sheep was 75.6% (90% upper credible limit (UCrL): 77.5%), while twice the recommended dose led to a reduction of 92.6% (90% UCrL: 93.3%). In goats, the FECRs of a therapeutic dose were 72.9-95.3% (90% UCrL range: 73.6-95.7%) in Bulbul, Nyala Domaia, Nyala University farm and Kass. Twice the dose recommended for goats in Bulbul revealed a 90% UCrL of 87.6%. All post-treatment faecal cultures contained only Haemonchus spp. larvae. The experimental infection trials in sheep and goats supported our findings from field trials and calculated upper 90% CrL of below 98.9%. For the first time highly ivermectin resistant H. contortus populations have been identified in sheep and goats in Sudan, and resistance was experimentally confirmed.
Sujet(s)
Résistance aux substances , Maladies des chèvres , Capra , Ivermectine , Nématodoses , Maladies des ovins , Animaux , Capra/parasitologie , Ivermectine/pharmacologie , Ivermectine/usage thérapeutique , Ovis/parasitologie , Maladies des ovins/traitement médicamenteux , Maladies des ovins/parasitologie , Maladies des chèvres/traitement médicamenteux , Maladies des chèvres/parasitologie , Soudan , Nématodoses/traitement médicamenteux , Nématodoses/médecine vétérinaire , Nématodoses/parasitologie , Fèces/parasitologie , Mâle , Numération des oeufs de parasites/médecine vétérinaire , Nematoda/effets des médicaments et des substances chimiques , Anthelminthiques/usage thérapeutique , Anthelminthiques/pharmacologie , Haemonchus/effets des médicaments et des substances chimiquesRÉSUMÉ
Anthelmintic resistance in sheep parasitic gastrointestinal nematodes is widespread and a severe health and economic issue but prevalence of resistance and involved parasite species are unknown in Germany. Here, the faecal egg count reduction test (FECRT) was performed on eight farms using fenbendazole, ivermectin and moxidectin and on four farms using only moxidectin. A questionnaire was used to obtain data on management practices to potentially identify risk factors for presence of resistance. All requirements of the recently revised WAAVP guideline for diagnosing anthelmintic resistance using the FECRT were applied. Nematode species composition in pre- and post-treatment samples was analysed with the nemabiome approach. Using the eggCounts statistic package, resistance against fenbendazole, ivermectin and moxidectin was found on 7/8, 8/8 and 8/12 farms, respectively. No formal risk factor analysis was conducted since resistance was present on most farms. Comparison with the bayescount R package results revealed substantial agreement between methods (Cohen's κ = 0.774). In contrast, interpretation of data comparing revised and original WAAVP guidelines resulted in moderate agreement (Cohen's κ = 0.444). The FECR for moxidectin was significantly higher than for ivermectin and fenbendazole. Nemabiome data identified 4 to 12 species in pre-treatment samples and treatments caused a small but significant decrease in species diversity (inverse Simpson index). Non-metric multidimensional scaling and k-means clustering were used to identify common patterns in pre- and post-treatment samples. However, post-treatment samples were scattered among the pre-treatment samples. Resistant parasite species differed between farms. In conclusion, the revised FECRT guideline allows robust detection of anthelmintic resistance. Resistance was widespread and involved multiple parasite species. Resistance against both drug classes on the same farm was common. Further studies including additional drugs (levamisole, monepantel, closantel) should combine sensitive FECRTs with nemabiome data to comprehensively characterise the anthelmintic susceptibility status of sheep nematodes in Germany.
Sujet(s)
Anthelminthiques , Fermes , Fèces , Macrolides , Numération des oeufs de parasites , Maladies des ovins , Animaux , Ovis , Allemagne/épidémiologie , Maladies des ovins/parasitologie , Maladies des ovins/épidémiologie , Numération des oeufs de parasites/méthodes , Numération des oeufs de parasites/médecine vétérinaire , Fèces/parasitologie , Anthelminthiques/pharmacologie , Macrolides/pharmacologie , Ivermectine/pharmacologie , Nématodoses/médecine vétérinaire , Nématodoses/parasitologie , Nématodoses/épidémiologie , Nématodoses/traitement médicamenteux , Fenbendazole/pharmacologie , Résistance aux substances , Nematoda/effets des médicaments et des substances chimiques , Nematoda/classification , Nematoda/isolement et purificationRÉSUMÉ
AIMS: To investigate the association between gastrointestinal parasites (GIP) and animal behaviour in dairy calves under New Zealand pastoral conditions, using animal-mounted, accelerometer-based sensors. METHODS: Thirty-six, 5-6-month-old, Friesian-Jersey, heifer calves fitted with animal activity sensors to track behaviour were randomly allocated to one of two treatment groups. Half the animals were challenged with an oral dose of 20,000 larvae of Ostertagia ostertagi and Cooperia oncophera once a week for 3 weeks and half were unchallenged. Five weeks after the last dose, seven infected and nine uninfected animals were treated with an oral anthelmintic (AHC) and data collected for a further week. Accelerometer data were classified into minutes per day eating, ruminating, in moderate-high activity or in low activity. Live weight and faecal egg counts (FEC) were recorded weekly over the study period. All animals co-grazed a newly sown pasture not previously grazed by ruminants and were moved every week to fresh grazing. Treatment status was blinded to those managing the animals which were otherwise treated identically. RESULTS: Complete behavioural records were available from 30/36 calves, (13 challenged and 17 unchallenged). Before treatment with AHC, FEC increased in infected and un-treated calves over the study, while uninfected animals maintained a near zero FEC. There was no difference in live weight gain between the two groups over the study period. Bayesian, multinomial regression predicted differences in animal behaviour between infected and uninfected animals that were not treated with AHC over the 7 weeks following initial infection. Parasitised calves not treated with AHC were less active and spent up to 6 (95% highest density interval (HDI) = 1-11) minutes/day less in low level activity and up to 15 (95% HDI = 7-20) minutes/day less in moderate to high level activity. They ruminated up to 9 (95% HDI = 2-15) minutes/day more and ate up to 10 (95% HDI = 2-19) minutes/day more than control calves that were not treated with AHC. The effect of AHC on time spent in each behaviour differed between infected and uninfected calves and increased the coefficient of dispersion of the behavioural data. CONCLUSIONS AND CLINICAL RELEVANCE: Small differences in animal behaviour can be measured in calves with GIP. However, to use this to target treatment, further validation studies are required to confirm the accuracy of behavioural classification and understand the complex drivers of animal behaviour in a dynamic and variable pasture-parasite-host environment.
Sujet(s)
Anthelminthiques , Comportement animal , Maladies des bovins , Animaux , Bovins , Maladies des bovins/parasitologie , Anthelminthiques/usage thérapeutique , Anthelminthiques/administration et posologie , Femelle , Nouvelle-Zélande , Numération des oeufs de parasites/médecine vétérinaire , Fèces/parasitologie , Ostertagia/effets des médicaments et des substances chimiques , Ostertagiose/médecine vétérinaire , Ostertagiose/traitement médicamenteux , Industrie laitièreRÉSUMÉ
PURPOSE: This study aimed to examine the species diversity and structure of the strongylid community in domestic horses in Eastern Slovakia. Also, an analysis of the impact of age, sex, and collection location factors on the strongyid communities was performed. METHODS: Twenty-seven horses 1.5-21 years old from two farms in eastern Slovakia with different horse-management conditions were studied. Strongylids were collected after horse treatments with Noromectin (0.2 mg ivermectin); 66,170 specimens were collected and identified. Faecal egg count reduction test (FECRT) was performed following fenbendazole (FBZ) and ivermectin (IVM) treatments. RESULTS: Twenty-four strongylid species were found; horses were infected with 6 to 16 (average = 11.7) species. Six cyathostomin species (Cylicocyclus nassatus, Cyathostomum catinatum, C. pateratum, Cylicostephanus longibursatus, C. goldi, C. calicatus) were the most prevalent; C. catinatum was the dominant species in both farms (Berger-Parker index 0.34 and 0.42). The structure of the strongylid community was multimodal with dominant, subdominant, background, and rare species. The Mantel test showed that horse age and sex did not significantly affect the nematode infracommunity composition (p > 0.05), while the impact of the collection location (farm) was significant (p = 0.03). Additionally, C. longibursatus was identified as the species contributing significantly to the observed farm differences. Strong resistance to FBZ was documented on both farms (FECRT was 36.4% and 22.7%); IVM resistance was not observed (FECRT = 100%). CONCLUSION: This study presents the first report on the strongylids parasitizing domestic horses in Eastern Slovakia and gives basic information for further studies of horse parasites and their control in the region.
Sujet(s)
Fèces , Maladies des chevaux , Numération des oeufs de parasites , Animaux , Equus caballus/parasitologie , Slovaquie/épidémiologie , Maladies des chevaux/parasitologie , Maladies des chevaux/épidémiologie , Mâle , Femelle , Numération des oeufs de parasites/médecine vétérinaire , Fèces/parasitologie , Infections à Strongylida/médecine vétérinaire , Infections à Strongylida/parasitologie , Infections à Strongylida/épidémiologie , Ivermectine , Biodiversité , Strongyloidea/classification , Strongyloidea/isolement et purification , Strongyloidea/effets des médicaments et des substances chimiquesRÉSUMÉ
The World Health Organization calls for schistosomiasis endemic countries to regularly monitor the efficacy of Praziquantel (PZQ) drug, the only antischistosomal drug used for four decades in Tanzania. In response to that call, the current study investigated the efficacy of single dose of PZQ against Schistosoma haematobium during the high transmission season and further assessed, the sensitivity and specificity of urine reagent strips before and after treatment. The study recruited a total of 2,498 -children aged (4 -17 years old) who provided a single urine sample that was visually examined for macro-haematuria, then using urine dipstick and urine filtration technique for microhaematuria and the presence of S. haematobium eggs. The baseline prevalence of S. haematobium eggs positive based on urine filtration test was 29.2â¯% (95â¯%CI:27.5-31.0) and that of microhaematuria was 43.1â¯% (95â¯%CI:41.1-45.0). Of the infected participants, 40.9â¯% (95â¯%CI:37.4-44.6) had a heavy intensity of infection and the geometrical mean intensity (GMI) of infection was 33.7 eggs/10mls of urine. A single dose of PZQ reduced the prevalence of infection to 16.2â¯%, the GMI of infection to 18.8eggs/10mls of urine and that of microhaematuria to 27.9â¯%. Cure rate and egg reduction rates (ERR) were 83.8â¯% and 44.3â¯% respectively. At baseline, the sensitivity and specificity of the urine reagent strips were 59.7â¯% and 93.8â¯%, whereas at post-treatment they were 16.7â¯% and 93.6â¯%. When PZQ drug is administered during the high transmission season, its efficacy in term of ERR is poor. The urine reagent strips had low sensitivity but high specificity at pre-and-post PZQ treatment.
Sujet(s)
Anthelminthiques , Praziquantel , Bandelettes réactives , Schistosoma haematobium , Bilharziose urinaire , Sensibilité et spécificité , Praziquantel/usage thérapeutique , Praziquantel/administration et posologie , Tanzanie/épidémiologie , Humains , Bilharziose urinaire/traitement médicamenteux , Bilharziose urinaire/urine , Bilharziose urinaire/épidémiologie , Enfant , Animaux , Enfant d'âge préscolaire , Femelle , Mâle , Anthelminthiques/usage thérapeutique , Anthelminthiques/administration et posologie , Schistosoma haematobium/effets des médicaments et des substances chimiques , Adolescent , Prévalence , Urine/parasitologie , Urine/composition chimique , Résultat thérapeutique , Numération des oeufs de parasitesRÉSUMÉ
Sustainable parasite control practices are necessary to combat the negative effects of gastrointestinal nematodes on animal health and production while reducing the selection pressure for anthelmintic resistance. Parasite diagnostic tests can inform treatment decisions, the timing and effectiveness of treatment and enable livestock breeding programmes. In recent years new diagnostic methods have been developed, some incorporating machine learning (ML), to facilitate the detection and enumeration of parasite eggs. It is important to understand the technical characteristics and performance of such new methods compared to long standing and commonly utilised methods before they are widely implemented. The aim of the present study was to trial three new diagnostic tools relying on image analysis (FECPAKG2, Micron and OvaCyte) and to compare them to traditional manual devices (McMaster and Mini-FLOTAC). Faecal samples were obtained from 41 lambs naturally infected with gastrointestinal nematodes. Samples were mixed and separated into 2 aliquots for examination by each of the 5 methods: McMaster, Mini-FLOTAC, FECPAKG2, Micron and OvaCyte. The techniques were performed according to their respective standard protocols and results were collected by trained staff (McMaster and Mini-FLOTAC) or by the device (FECPAKG2, Micron and OvaCyte). Regarding strongyle worm egg count, McMaster values varied from 0 to 9,000 eggs per gram (EPG). When comparing replicate aliquots, both the Mini-FLOTAC and Micron methods displayed similar repeatability to McMaster. However, we found FECPAKG2 and OvaCyte significantly less precise than McMaster. When comparing parasite egg enumeration, significant positive linear correlations were established between McMaster and all other methods. No difference was observed in EPG between McMaster and Mini-FLOTAC or FECPAKG2; however, Micron and OvaCyte returned significantly higher and lower EPG, respectively, compared to McMaster. The number of eggs ascribed to other parasite species was not sufficient for performing a robust statistical comparison between all methods. However, it was noted that FECPAKG2 generally did not detect Strongyloides papillosus eggs, despite these being detected by other methods. In addition, Moniezia spp and Trichuris spp eggs were detected by OvaCyte and Mini-FLOTAC, respectively, but not by other methods. The observed variation between traditional and new methods for parasite diagnostics highlights the need for continued training and enhancing of ML models used and the importance of developing clear guidelines for validation of newly developed methods.